February 28, 2019 / 2:48 PM / 3 months ago

Starboard to vote against Bristol-Myers-Celgene $74 bln deal

Feb 28 (Reuters) - Activist investor Starboard Value LP will vote against Bristol-Myers Squibb Co's $74 billion acquisition of Celgene Corp, the hedge fund said on Thursday, adding to the number of shareholders declaring against the deal.

Starboard's letter comes a day after Wellington Management, which owns nearly 8 percent of Bristol-Myers, said the buyout was too risky and expensive.

Bristol-Myers investors are due to vote on the deal at a special meeting scheduled for April 12. (Reporting by Ankur Banerjee in Bengaluru; Editing by Anil D'Silva)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below